Patients suffering from one of the following medical conditions can participate in Pennsylvania’s medical marijuana program:
- Amyotrophic lateral sclerosis.
- Anxiety disorders.
- Cancer, including remission therapy.
- Crohn’s disease.
- Damage to the nervous tissue of the central nervous system (brain-spinal cord) with objective neurological indication of intractable spasticity, and other associated neuropathies.
- Dyskinetic and spastic movement disorders.
- HIV / AIDS.
- Huntington’s disease.
- Inflammatory bowel disease.
- Intractable seizures.
- Multiple sclerosis.
- Neurodegenerative diseases.
- Opioid use disorder for which conventional therapeutic interventions are contraindicated or ineffective, or for which adjunctive therapy is indicated in combination with primary therapeutic interventions.
- Parkinson’s disease.
- Post-traumatic stress disorder.
- Severe chronic or intractable pain of neuropathic origin or severe chronic or intractable pain.
- Sickle cell anemia.
- Terminal illness.
- Tourette syndrome.
Drug overdose deaths continue to impact communities across the United States. Drug overdose deaths are still high:
- From 1999 to 2018, over 750,000 people died from a drug overdose.
- In 2018, almost 70,000 people died from drug overdoses.
- Two out of three overdose deaths involved opioid-like prescription opioids, heroin, or synthetic opioids (like fentanyl).
Take control of your health care and get off the pharmaceuticals.